Spero Health — a privately held substance use disorder treatment (SUD) provider with dozens of locations across five states — has opened a new clinic in Martinsville, Virginia.
The facility is the sixth new center Spero Health has announced since the COVID-19 emergency began in mid-March. It’s all part of the provider’s plan to offer affordable regional coverage for addiction treatment services to communities in need, according to a press release announcing the news.
“Drug overdose deaths have risen steadily through the pandemic because more people are isolated and feeling vulnerable right now,” Steve Priest, CEO of Spero Health, said in the press release. “It is critical our communities have immediate access to addiction treatment services now more than ever.”
Nashville-based Spero Health is privately held by Heritage Group, Health Velocity Capital, South Central, Inc. and Frist Cressey Ventures. It offers community-based treatment using an integrated care model to serve more than 7,500 patients per month across Kentucky, Ohio, Tennessee, Indiana and Virginia.
The new Martinsville clinic is the latest addition to that network.
Spero Health chose the location based in part on data: In 2019, rates of unintentional overdoses in the country were the second highest of any in the state of Virginia. Plus, a 2017 report from the U.S. Centers for Disease Control and Prevention (CDC) indicated that patients in Martinsville were prescribed more opioids than anywhere else in the country.
Like other centers in Spero Health’s network, the new clinic will offer both in-person and telehealth treatment options and serve patients with Medicaid and most commercial insurance plans.
